- As One Spouse’s Blood Pressure Rises, So Does the Other’s: Study
- Folks at High Risk of Heart Disease May Gain From Eating Mackerel, Tuna
- Minorities Expect and Prepare for Unfair Health Care, Survey Shows
- Women Need Better Guidance on Exercise & the Menstrual Cycle, Study Shows
- State Abortion Bans Have New Doctors Staying Away
- Mind, Body Symptoms Can Precede MS Diagnosis for Years
- Starting Periods Early Linked to Higher Odds for Diabetes, Stroke
- Spotting Epilepsy in Kids Isn’t Always Easy: Know the Signs
- New Syndrome May Be Affecting Babies Exposed to Fentanyl
- Wasabi Shows Memory-Boosting Powers in Study
Extended-Release Hydrocodone Painkiller Approved
FRIDAY, Oct. 25Zohydro ER (hydrocodone bitartrate extended-release) has been approved by the U.S. Food and Drug Administration for severe pain that requires round-the-clock long-term treatment, the agency said Friday in a news release.
Citing the potential for opioid abuse or dependency, even if the product is used as prescribed, the agency said the drug should be used only in cases when other painkillers have proven ineffective. The schedule II controlled substance should only be used to treat daily, chronic pain, not for as-needed pain relief, the FDA said.
The agency said it has ordered post-marketing studies of Zohydro ER to evaluate use beyond 12 weeks, and its overall potential for abuse.
The drug was evaluated in clinical studies involving more than 1,100 people with chronic pain. The most common side effects included constipation, nausea, drowsiness, headache, dizziness, dry mouth and itching.
Zohydro ER is produced by Zogenix, based in San Diego.
More information
To learn more about chronic pain, visit the U.S. National Institute of Neurological Disorders and Stroke.
Source: HealthDay
Copyright © 2023 HealthDay. All rights reserved.
Related
-
Starting Periods Early Linked to Higher Odds for Diabetes, StrokeGirls whose periods begin before the age of 13...
- December 6, 2023
-
Timing of Menopause Could Affect a Woman’s Muscle LossWomen who enter menopause early could be at increased...
- December 4, 2023
-
‘Couch Potato’ Lifestyle Could Raise Women’s Odds for FibroidsWomen in a Chinese study who sat for more...
- November 30, 2023
-
More Evidence That Regular Mammograms Save LivesA woman who gets her regular mammograms as scheduled...
- November 30, 2023
